π©ΈCPT Code 43244 β Esophagogastroduodenoscopy, Flexible, Transoral; with Band Ligation of Esophageal and/or Gastric Varices
Quick Reference
Global Period: 000 days | wRVU: 5.35 | Assistant Payable: β No | Co-Surgeon: β No | Category: Surgery - Digestive System | Setting: Hospital / ASC | Procedure: Endoscopic Variceal Band Ligation (EVL) | Primary Context: Portal Hypertension / Cirrhosis / GI Hemorrhage
π Official CPT Description
CPT 43244 β Esophagogastroduodenoscopy, flexible, transoral; with band ligation of esophageal and/or gastric varices
This code describes a flexible transoral upper gastrointestinal endoscopy (EGD) that includes endoscopic variceal ligation (EVL) β the therapeutic application of rubber band(s) to esophageal varices and/or gastric varices to achieve hemostasis (control of active hemorrhage), prevent rebleeding (secondary prophylaxis), or eradicate varices (elective primary or secondary prophylaxis). The procedure involves deploying one or multiple elastic bands over each variceal column, causing mechanical strangulation, thrombosis, and eventual sloughing of the banded tissue β obliterating the varix.
CPT 43244 is the most important therapeutic endoscopic code in the management of portal hypertension and is among the most commonly performed emergent upper GI endoscopic interventions in hospitalized patients with cirrhosis and acute variceal hemorrhage.
π§ Detailed Clinical Description
Pathophysiology β Why Varices Form
Esophageal and gastric varices are portosystemic venous collaterals that develop as a consequence of portal hypertension β elevated pressure in the portal venous system above a hepatic venous pressure gradient (HVPG) threshold of β₯10-12 mmHg.
Portal hypertension β increased resistance to portal blood flow (primarily at the hepatic sinusoidal level in cirrhosis) β portal-systemic collateral development β blood diverted through naturally occurring portosystemic connections β submucosal venous dilation at the gastroesophageal junction (where the systemic and portal venous systems communicate through the coronary/left gastric vein β esophageal submucosal plexus β azygos/hemiazygos system).
Key venous anatomy:
| Vessel | Role in Variceal Formation |
|---|---|
| Portal vein | Receives mesenteric, splenic, and gastric venous drainage; elevated pressure in portal hypertension |
| Left gastric (coronary) vein | Primary feeder vessel for esophageal varices; portal β left gastric β perforating veins β submucosal esophageal plexus |
| Short gastric veins | Feed fundal/gastric varices via splenic β short gastric β fundal submucosal plexus |
| Esophageal submucosal venous plexus | Site of variceal dilation β columns of distended veins in distal esophageal submucosa |
| Azygos/hemiazygos system | Systemic venous drainage of esophageal varices into superior vena cava |
| Paraesophageal perforating veins | Connect esophageal submucosal plexus to paraesophageal adventitial veins |
Variceal Classification and Grading
Esophageal Variceal Grading (Sarin / Japanese Classification):
| Grade | Description | Bleed Risk |
|---|---|---|
| F1 (small/Grade 1) | Straight, small varices; disappear with insufflation | Low |
| F2 (medium/Grade 2) | Tortuous, medium varices; partially occlude lumen; do not disappear with insufflation | Moderate |
| F3 (large/Grade 3) | Large, coiling varices; markedly occlude lumen; high-risk stigmata (red wale marks, cherry red spots) | High |
High-risk endoscopic features (red signs):
| Sign | Description | Clinical Significance |
|---|---|---|
| Red wale marks (RWM) | Longitudinal red streaks on variceal surface | Highest predictor of hemorrhage |
| Cherry red spots | Discrete red areas on variceal surface | High hemorrhage risk |
| Hematocystic spots | Dark red blood blisters on varix | Very high bleed risk β thin wall |
| Diffuse erythema | Generalized redness of variceal surface | Moderate risk |
Sarin Classification of Gastric Varices (GOV/IGV):
| Type | Location | Clinical Context |
|---|---|---|
| GOV1 | Gastroesophageal varices extending along lesser curvature | Most common; extension of esophageal varices |
| GOV2 | Gastroesophageal varices extending along fundus/greater curvature | Larger; more complex |
| IGV1 | Isolated gastric varices β fundal | Splenic vein thrombosis; high bleed risk |
| IGV2 | Isolated gastric varices β elsewhere (antrum, body) | Rare; varied etiology |
EVL vs. Tissue Adhesive (Cyanoacrylate) for Gastric Varices
Band ligation (EVL) is the first-line endoscopic treatment for esophageal varices and GOV1 varices. For fundal gastric varices (GOV2, IGV1), cyanoacrylate (tissue glue) injection is generally preferred over EVL due to the deeper, larger variceal channels that EVL bands cannot adequately strangulate. 43244 applies to both esophageal and gastric varices β however, document explicitly whether the procedure involved esophageal, GOV1, or fundal varices, as technique and outcomes differ significantly.
How Band Ligation Works β Technical Mechanism
Endoscopic variceal ligation (EVL) achieves variceal obliteration through mechanical strangulation:
- Band deployment device loaded onto the endoscope tip β multiband ligator (typically 6, 7, 8, or 10 bands per session) eliminates need to withdraw scope for reloading
- Varix suctioned into the transparent cap at scope tip β creating a pseudopolyp of variceal tissue
- Band released β elastic ring drops from the cap over the base of the suctioned pseudopolyp, mechanically strangulating the varix
- Ischemic necrosis develops over 48-72 hours β banded tissue undergoes thrombosis and infarction
- Sloughing occurs at 5-10 days β band + banded tissue slough off, leaving a shallow ulcer
- Ulcer heals at 2-3 weeks β fibrosis replaces variceal channel, obliterating blood flow
- Repeat sessions (typically every 2-4 weeks) until all variceal columns eradicated (typically 3-5 sessions for complete variceal eradication)
Multiband Ligator β Equipment
| Device | Bands per Load | Scope Compatibility | Clinical Advantage |
|---|---|---|---|
| Saeed Multi-Band Ligator (Wilson-Cook) | 6 bands | Standard 2.8 mm channel | Pioneer device; widely used |
| Speedband Superview (Boston Scientific) | 7 bands | 2.8 mm channel | Clear cap; improved visualization |
| HX-21L-1 (Olympus) | 6 bands | 2.8 mm channel | Reliable deployment |
| Stiegmann-Goff (Endovations) | Single-fire (historical) | Requires withdrawal for reload | Historical reference |
| 10-band devices | 10 bands | Therapeutic channel | High-volume variceal sessions |
Single vs. Multiple Bands β One Code
Whether 1 band or 10 bands are deployed during a single EVL session, the correct code is one unit of 43244. The code does not differentiate by number of bands applied or number of variceal columns treated. Document the number of bands deployed and variceal columns treated in the procedure report β this provides clinical context for surveillance planning and follow-up.
Clinical Contexts for 43244
| Clinical Context | Description | Urgency |
|---|---|---|
| Acute variceal hemorrhage β esophageal | Active bleeding from esophageal varices identified at emergency EGD; EVL applied for hemostasis | π¨ Emergent (within 12 hours of admission) |
| Acute variceal hemorrhage β gastric (GOV1) | Active bleeding from GOV1 gastroesophageal varices; EVL as primary hemostasis | π¨ Emergent |
| Secondary prophylaxis | Prior variceal bleed; EVL to eradicate remaining varices and prevent rebleeding | β‘ Urgent-Elective |
| Primary prophylaxis | Large varices (F2/F3) or high-risk stigmata (red signs); EVL to prevent first bleed in high-risk patients | π Elective |
| Variceal eradication program | Serial EVL sessions every 2-4 weeks until all variceal columns eradicated | π Elective (surveillance program) |
| Pre-liver transplant preparation | Variceal eradication to reduce perioperative hemorrhage risk | π Elective |
| Portal hypertension β pediatric | Extrahepatic portal vein obstruction, congenital hepatic fibrosis, pediatric cirrhosis | π Varies |
Indications for 43244 β Guidelines Summary
Primary Prophylaxis (EVL to prevent first bleed):
- Medium-large varices (F2/F3) in patients with cirrhosis
- Small varices (F1) with red wale signs or advanced liver disease (Child-Pugh C)
- Beta-blocker intolerance or contraindication β EVL is preferred alternative
Secondary Prophylaxis (EVL after prior bleed):
- All patients who survive acute variceal hemorrhage should receive combined EVL + non-selective beta-blocker therapy for secondary prophylaxis (AASLD, ACG guidelines)
- EVL sessions repeated every 2-4 weeks until variceal eradication
- Surveillance EGD 3-6 months after eradication, then annually
Acute Hemorrhage:
- EGD (including EVL if varices identified) within 12 hours of presentation per AASLD guidelines
- EVL is first-line treatment for acute esophageal variceal hemorrhage
- Balloon tamponade (Sengstaken-Blakemore tube) or TIPS if EVL fails
Surgical Steps Included in 43244
- Pre-procedure preparation β Airway protection assessment; prophylactic endotracheal intubation considered for active hemorrhage; IV access; blood product availability; octreotide infusion started pre-procedure; antibiotic prophylaxis (norfloxacin or ceftriaxone); NPO; informed consent
- Sedation β IV moderate sedation (midazolam + fentanyl) or MAC/general anesthesia (for active hemorrhage or encephalopathic patient); anesthesia provider present for high-acuity cases
- Multiband ligator loading β Ligator device loaded onto endoscope with transparent cap secured; trigger mechanism tested; bands preloaded (6-10 bands)
- Scope introduction β Transoral passage under direct vision; bite block positioned; scope advanced through oropharynx, UES, esophagus
- Initial diagnostic survey β Entire esophagus, stomach (including retroflexion for cardia/fundal varices), and duodenum examined; variceal extent, grade, and stigmata documented; source of bleeding identified
- Variceal mapping β All variceal columns identified by position (anterior, posterior, left, right) and distance from incisors; grade, stigmata, active bleeding site documented
- Band ligation β technique: a. Scope tip with ligator cap positioned at target varix (typically starting distally at GEJ level and working proximally) b. Suction applied β varix aspirated into cap; pseudopolyp formation confirmed visually c. Band trigger activated β band released; pseudopolyp βfire-hydrantβ appearance confirms correct band placement d. Suction released; scope repositioned for next varix e. Procedure repeated at each variceal column and each level; working from GEJ proximally
- Active hemorrhage management β Additional bands applied at or above bleeding point; hemostasis confirmed visually; band placement over adherent clot or bleeding vessel
- Documentation β Number of bands deployed, variceal columns treated, pre/post-EVL appearance, hemostasis status, residual varices
- Scope withdrawal β Complete examination on withdrawal; post-EVL inspection of banded sites
- Post-procedure management β Patient monitored in recovery; post-band instructions (soft diet Γ1 week; PPI therapy to reduce banding ulcer risk; octreotide infusion continued 3-5 days for acute bleed; antibiotic prophylaxis completed)
π° Reimbursement & RVU Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | 5.35 CMS MPFS 2025 |
| Global Period | 000 days |
| Assistant Surgeon Payable | β No (Indicator: 0) |
| Co-Surgeon Payable | β No |
| Team Surgery | β No |
| Facility RVU | β Yes |
| Non-Facility RVU | β Yes |
| Multiple Procedure Indicator | 2 (standard reduction applies) |
| Bilateral Surgery Indicator | 0 |
wRVU Comparison β EGD Therapeutic Family
Code wRVU Procedure 43235 ~3.50 EGD diagnostic 43239 ~4.43 EGD with biopsy 43244 5.35 EGD with band ligation β varices (this code) 43243 ~5.12 EGD with injection sclerosis of varices 43245 ~5.50 EGD with dilation of gastric outlet 43247 ~5.90 EGD with foreign body removal 43249 ~4.30 EGD with balloon dilation β€30 mm 43251 ~5.10 EGD with snare polypectomy 43254 ~7.55 EGD with EMR 43255 ~5.92 EGD with control of bleeding At 5.35 wRVU, 43244 reflects the clinical intensity and technical demands of variceal band ligation β particularly in the acute hemorrhage context where the procedure is performed under emergency conditions on critically ill patients with coagulopathy, thrombocytopenia, and active bleeding. Multiple serial EVL sessions over weeks to months for variceal eradication programs generate significant cumulative wRVU for hepatology and GI practices.
Facility vs. Non-Facility RVU
43244 is performed almost exclusively in facility settings (hospital inpatient, hospital outpatient, or ASC) due to the sedation requirements, equipment needs, and acuity of the patient population. Non-facility (office) performance is rare. The facility bills separately for the procedure facility component under the applicable APC (hospital outpatient) or ASC payment rate.
β Included Services (Bundled into 43244)
The following are not separately reportable when performed as integral components of 43244:
- Complete flexible transoral EGD β examination of esophagus, stomach, and duodenum
- All scope maneuvers including retroflexion for cardia/fundal assessment
- Initial diagnostic survey of the entire upper GI tract (esophagus, stomach, duodenum)
- Variceal mapping and grading documentation
- Multiband ligator device loading and attachment to scope
- All band deployments during a single EVL session β regardless of number of bands or columns treated
- Suction maneuver for varix capture (pseudopolyp formation)
- Post-ligation hemostasis assessment
- Moderate sedation when administered by the same endoscopist
- Topical pharyngeal anesthesia
- Routine photography and video documentation
- Standard scope withdrawal with post-EVL inspection
- Post-procedure patient monitoring (office/ASC setting)
- Routine post-procedure instructions
β Excludes / Separately Reportable Services
The following may be billed separately when clearly documented as distinct services:
| Separate Service | Code |
|---|---|
| EGD diagnostic only (if EVL not performed) | 43235 |
| EGD with biopsy (if biopsy obtained in addition to EVL) | 43239 |
| EGD with injection sclerosis of varices | 43243 |
| EGD with control of non-variceal bleeding (if bleeding source separate from varices) | 43255 |
| EGD with foreign body removal (separate from EVL) | 43247 |
| EGD with dilation of esophageal stricture (same session, distinct indication) | 43249 |
| Anesthesia/MAC/GA by separate provider | Anesthesia codes β billed by anesthesia provider |
| Moderate sedation by separate observer physician | 99152, 99153 |
| TIPS (transjugular intrahepatic portosystemic shunt) β if performed after failed EVL | Interventional radiology codes 37182 |
| Balloon tamponade (Sengstaken-Blakemore) β if placed before/after EVL | 43460 |
| Liver biopsy β if separately performed | 47000, 47001 |
| Paracentesis β if separately performed | 49082, 49083 |
| Critical care services (if separately provided by different physician on same day) | 99291, 99292 |
| Pathology β if biopsy specimen separately obtained | 88305 β billed by pathologist |
| Capsule endoscopy (small bowel) | 91110, 91111 |
| Return to OR/endoscopy suite for related re-bleeding | 43244 with modifier -78 |
| Colonoscopy (if separately performed for lower GI bleeding evaluation) | 45378-45398 |
43255 (EGD with control of bleeding, any method) and 43244 (EGD with band ligation) are mutually exclusive for variceal hemorrhage in the same session β you cannot bill both for variceal bleeding controlled by band ligation. When EVL is performed to control active variceal bleeding, the correct code is 43244 β not 43255. 43255 is appropriate for non-variceal bleeding sources (ulcer with injection/cautery, Mallory-Weiss tear with clips, etc.).
However, if the same EGD session encounters BOTH:
- Active variceal bleeding controlled by EVL (43244)
- A SEPARATE non-variceal bleeding source (e.g., concurrent gastric ulcer with visible vessel controlled by injection/cautery)
β Both 43244 AND 43255 may be separately reportable with modifier -59 and explicit documentation of two distinct bleeding sources and two distinct therapeutic interventions at separate anatomical sites. Verify NCCI and document meticulously.
43243 (EGD with injection sclerosis of varices) and 43244 (EGD with band ligation) should not be billed together for the same variceal treatment session. Combined EVL + sclerotherapy is not standard of care (EVL is now preferred over sclerotherapy) and NCCI bundles these when performed in the same session. Use 43244 when EVL is the primary technique.
When 43244 (EVL) is performed AND a biopsy is obtained at a separate, distinct site (e.g., gastric biopsy for H. pylori or Barrettβs surveillance biopsy) during the same EGD session, both codes may be separately reportable:
Apply modifier 59 to 43239 and document the biopsy site as distinctly separate from the variceal treatment site. Verify NCCI edits before submitting both codes. Some payers will bundle 43239 into 43244 regardless; be prepared for prior authorization or appeal.
π¬ Comparison β 43244 vs. 43243 (EVL vs. Sclerotherapy)
Historical Context and Current Standard of Care
| Feature | 43244 β Band Ligation (EVL) | 43243 β Injection Sclerosis |
|---|---|---|
| Technique | Mechanical band strangulation | Chemical injection (sclerosant) into/around varix |
| Sclerosant/material | Rubber bands (no chemical) | Ethanolamine, sodium tetradecyl sulfate, polidocanol |
| Current standard of care | β First-line β preferred | β Historical β largely replaced by EVL |
| Efficacy β hemostasis | 90-95% initial hemostasis | 85-90% |
| Rebleeding risk | Lower | Higher |
| Complication rate | Lower | Higher (stricture, perforation) |
| Sessions to eradication | 3-5 sessions | 4-6 sessions |
| wRVU | 5.35 | 5.12 |
| When used today | Primary and secondary prophylaxis; acute hemorrhage | Selected cases where EVL technically difficult; no longer first-line |
EVL (43244) has largely supplanted sclerotherapy (43243) in modern variceal management. Sclerotherapy (43243) is now used primarily when EVL is technically not feasible (very small varices not amenable to banding, equipment failure) or in certain pediatric cases. In contemporary practice, nearly all EVL coding should use 43244.
π·οΈ Applicable Modifiers
| Modifier | Description | When to Use |
|---|---|---|
| -51 | Multiple procedures | When 43244 is performed alongside another distinct procedure (e.g., separately indicated biopsy 43239, colonoscopy 45378) in the same session; append to lesser-valued code |
| -59 | Distinct procedural service | To unbundle a separately identifiable service at a distinct anatomical site β e.g., biopsy (43239) for H. pylori at gastric antrum separate from variceal EVL; or non-variceal bleeding control (43255) at separate site; verify NCCI |
| -22 | Increased procedural complexity | Active massive hemorrhage with limited visualization; encephalopathic patient requiring general anesthesia; prior failed EVL with anatomic distortion; complex GOV2/IGV1 gastric varices requiring prolonged procedure; significantly extended OR/endoscopy time; must be specifically documented |
| -52 | Reduced services | Intended EVL session partially completed β e.g., only 2 variceal columns treated due to acute respiratory decompensation; describe extent of treatment provided |
| -53 | Discontinued procedure | Procedure terminated after initiation due to patient safety threat (cardiac arrest, aspiration, equipment failure mid-procedure) before EVL completed |
| -73 | Discontinued outpatient prior to anesthesia | ASC setting β procedure cancelled before anesthesia administered |
| -74 | Discontinued outpatient after anesthesia | ASC β procedure stopped after anesthesia started but before EVL completed |
| -76 | Repeat procedure by same physician | Same EVL session repeated same day by same physician β e.g., initial session for acute hemorrhage + second session same day for rebleeding |
| -77 | Repeat procedure by different physician | EVL performed by different physician same day β e.g., covering endoscopist performs urgent repeat EVL for rebleeding after primary endoscopistβs initial EVL |
| -78 | Return to OR/endoscopy suite for related procedure during global period | Repeat EVL for rebleeding within the 0-day global (note: 0-day global means global period is technically that calendar date only; modifier 78 may apply for related procedures within a concurrent surgical package) |
| -79 | Unrelated procedure during postoperative period | Unrelated procedure within global period of concurrent surgical service |
| -GC | Teaching physician service | Resident performed the EVL under direct supervision of teaching physician |
| -GR | Rural health clinic | Service performed at rural health clinic |
The following scenarios most strongly support modifier 22 for EVL:
- Active hemorrhage with poor visualization β Massive hematemesis filling the esophageal lumen; repeated lavage required; limited endoscopic visualization; extended procedure time
- Encephalopathic patient requiring GA β Need for endotracheal intubation and general anesthesia due to encephalopathy; aspiration risk management adds significant complexity
- Failed initial EVL β repeat session for persistent bleeding β Technically demanding re-banding in a field with prior band ulcers, sloughed tissue, and active rebleeding
- Large GOV2/IGV1 gastric varices β Fundal varices requiring extended technical maneuvering with retroflexion and difficult cap positioning
- Markedly coagulopathic patient β INR >3, platelets <30,000 β bleeding complications during banding requiring intraoperative management
- Prior TIPS or surgical shunt β Altered portal hemodynamics affecting variceal anatomy and behavior
Document: actual procedure time vs. typical; specific technical challenges encountered; additional resources required (anesthesia provider, additional nursing staff); patient co-management complexity.
π©Ί ICD-10-CM Diagnoses Commonly Paired with 43244
Esophageal Varices β Primary Diagnoses
| ICD-10-CM | Description | HCC? |
|---|---|---|
| I85.00 | Esophageal varices without bleeding | β |
| I85.01 | Esophageal varices with bleeding | β |
| I85.10 | Secondary esophageal varices without bleeding | β |
| I85.11 | Secondary esophageal varices with bleeding | β |
- Use I85.01 (esophageal varices with bleeding) when:
- Active hemorrhage is documented at the current encounter
- EVL is performed for acute hemostasis
- Hematemesis, melena, or hemodynamic instability attributable to variceal bleeding is present
- Use I85.00 (esophageal varices without bleeding) when:
- EVL is performed for elective prophylaxis (primary or secondary) without current active bleeding
- Surveillance session or eradication program continuation without active hemorrhage
I85.01 is not a CC or MCC on its own β but the associated comorbidities (cirrhosis, hepatic failure, coagulopathy) drive the DRG into high-tier weights. Accurate documentation of bleeding vs. non-bleeding status is clinically and administratively critical.
Primary vs. Secondary Esophageal Varices
- I85.0x (Primary esophageal varices) β Varices due to cirrhosis or primary portal hypertension; the most common etiology
- I85.1x (Secondary esophageal varices) β Varices due to non-cirrhotic portal hypertension β portal vein thrombosis, splenic vein thrombosis, hepatic vein obstruction (Budd-Chiari), congenital hepatic fibrosis, extrahepatic portal vein obstruction
Verify the underlying etiology from the medical record before selecting primary vs. secondary. Most adult cirrhotic patients β I85.0x; portal vein thrombosis patients β I85.1x.
Gastric Varices
| ICD-10-CM | Description | HCC? |
|---|---|---|
| I86.4 | Gastric varices | β |
I86.4 β Gastric Varices
ICD-10-CM provides a single code for gastric varices (I86.4) without the bleeding/non-bleeding distinction that exists for esophageal varices (I85.0x, I85.1x). When band ligation is performed for gastric varices (GOV1, GOV2, or IGV), code I86.4 as the primary diagnosis. When BOTH esophageal and gastric varices are treated in the same session (common in GOV1), code I85.01 or I85.00 (esophageal β with or without bleeding) as principal, with I86.4 as an additional diagnosis.
Cirrhosis and Liver Disease β Underlying Etiology Codes
| ICD-10-CM | Description | HCC? |
|---|---|---|
| K70.30 | Alcoholic cirrhosis of liver without ascites | β HCC 27 |
| K70.31 | Alcoholic cirrhosis of liver with ascites | β HCC 27 |
| K70.10 | Alcoholic hepatitis without ascites | β |
| K70.11 | Alcoholic hepatitis with ascites | β |
| K70.40 | Alcoholic hepatic failure without coma | β HCC 27 |
| K70.41 | Alcoholic hepatic failure with coma | β HCC 27 |
| K71.10 | Toxic liver disease with hepatic necrosis, without coma | β HCC 27 |
| K72.00 | Acute and subacute hepatic failure without coma | β HCC 27 |
| K72.01 | Acute and subacute hepatic failure with coma | β HCC 27 |
| K72.10 | Chronic hepatic failure without coma | β HCC 27 |
| K72.11 | Chronic hepatic failure with coma | β HCC 27 |
| K72.90 | Hepatic failure, unspecified, without coma | β HCC 27 |
| K72.91 | Hepatic failure, unspecified, with coma | β HCC 27 |
| K74.0 | Hepatic fibrosis | β |
| K74.1 | Hepatic sclerosis | β |
| K74.2 | Hepatic fibrosis with hepatic sclerosis | β |
| K74.60 | Unspecified cirrhosis of liver | β HCC 27 |
| K74.69 | Other cirrhosis of liver | β HCC 27 |
| K76.6 | Portal hypertension | β |
| K76.7 | Hepatorenal syndrome | β HCC 27 |
Cirrhosis β HCC 27 β Critical for Risk Adjustment
All confirmed cirrhosis codes (K70.30, K70.31, K74.60, K74.69) carry HCC 27 (chronic liver disease and cirrhosis) β a significant risk-adjustment driver in Medicare Advantage and value-based care contracts. This HCC must be captured at every encounter where cirrhosis is documented and managed β including every EVL session. In patients undergoing serial EVL for variceal eradication (typically 3-5 sessions), HCC 27 should appear as an additional diagnosis on each claim.
Additionally, hepatic failure (K72.10, K72.11, K72.90, K72.91) carries HCC 27 with even greater specificity β and K72.x1 (with coma β hepatic encephalopathy) is an MCC in the inpatient DRG system, dramatically escalating DRG weight.
Hepatitis β Viral Etiologies
| ICD-10-CM | Description | HCC? |
|---|---|---|
| B18.1 | Chronic viral hepatitis B without delta-agent | β HCC 29 |
| B18.2 | Chronic viral hepatitis C | β HCC 29 |
| B18.0 | Chronic viral hepatitis B with delta-agent | β HCC 29 |
| B19.10 | Unspecified viral hepatitis B without hepatic coma | β HCC 29 |
| B19.20 | Unspecified viral hepatitis C without hepatic coma | β HCC 29 |
| Z87.39 | Personal history of other musculoskeletal disorders (not applicable β see below) | β |
Viral Hepatitis β HCC 29 Capture
Chronic viral hepatitis B (B18.1) and chronic viral hepatitis C (B18.2) each carry HCC 29 (chronic hepatitis). When a patient with viral hepatitis-related cirrhosis undergoes EVL, code both the cirrhosis (K74.60 or etiologic cirrhosis code β HCC 27) and the underlying viral hepatitis (B18.1 or B18.2 β HCC 29). Two separate HCCs capture the dual disease burden and the complete clinical picture. This is a high-yield HCC pairing for hepatology-based practices.
Complications of Portal Hypertension and Cirrhosis
| ICD-10-CM | Description | HCC? |
|---|---|---|
| K76.6 | Portal hypertension | β |
| K76.7 | Hepatorenal syndrome | β HCC 27 |
| K70.31 | Alcoholic cirrhosis with ascites | β HCC 27 |
| R18.0 | Malignant ascites | β |
| R18.8 | Other ascites | β |
| K76.89 | Other specified diseases of liver (hepatic encephalopathy β use K72.x) | β |
| K72.91 | Hepatic failure, unspecified, with coma (encephalopathy) | β HCC 27 |
| D65 | Disseminated intravascular coagulation (DIC) | β HCC 38 |
| D68.4 | Acquired coagulation factor deficiency | β |
| D69.6 | Thrombocytopenia, unspecified (hypersplenism) | β |
GI Bleeding β Symptom and Complication Codes
| ICD-10-CM | Description | HCC? |
|---|---|---|
| K92.0 | Hematemesis | β |
| K92.1 | Melena | β |
| K92.2 | GI hemorrhage, unspecified | β |
| D62 | Acute posthemorrhagic anemia | β |
| T45.515A | Adverse effect of anticoagulants, initial encounter | β |
| Z79.01 | Long-term use of anticoagulants | β |
Sequencing β Esophageal Varices with Bleeding vs. GI Hemorrhage Symptom
When active variceal hemorrhage is the indication for 43244:
- Principal diagnosis = I85.01 (esophageal varices with bleeding) β the condition driving the admission/procedure
- NOT K92.0 (hematemesis) or K92.2 (GI hemorrhage, unspecified) as principal β these are symptom codes; when the cause (variceal bleeding) is known, code the etiology as principal, not the symptom
- D62 (acute posthemorrhagic anemia) β assign as additional diagnosis when the hemorrhage results in clinically significant anemia requiring treatment (transfusion, IV iron, monitoring)
Per ICD-10-CM outpatient coding guidelines: when a definitive diagnosis is established β code the definitive diagnosis, not the symptom. Per inpatient guidelines: sequence the condition most responsible for occasioning the admission.
Hepatocellular Carcinoma (HCC) β Malignant Cirrhosis
| ICD-10-CM | Description | HCC? |
|---|---|---|
| C22.0 | Liver cell carcinoma (hepatocellular carcinoma) | β HCC 11 |
| C22.1 | Intrahepatic bile duct carcinoma | β HCC 11 |
| C22.9 | Malignant neoplasm of liver, unspecified | β HCC 11 |
| Z85.05 | Personal history of malignant neoplasm of liver | β |
HCC (Hepatocellular Carcinoma) in the Context of Cirrhosis-Related Varices
Many patients undergoing EVL for varices have concurrent hepatocellular carcinoma (HCC) as a complication of cirrhosis β particularly in HBV and HCV-related cirrhosis. When HCC is documented:
- Code C22.0 (hepatocellular carcinoma β HCC 11) as an additional diagnosis alongside the cirrhosis and variceal codes
- Do not code both C22.0 and K74.60 if the cirrhosis code better captures the underlying disease context β however, in practice, both are commonly coded to fully represent the disease burden
- Hepatocellular carcinoma (HCC the disease, not the coding term) carries the HCC 11 risk-adjustment category β a high-tier malignancy weight
- This pairing (I85.01 + K74.69 + C22.0) generates three separate HCC-contributing diagnoses in a single encounter β highly significant for value-based care risk scores
Alcohol Use Disorder β Comorbidity
| ICD-10-CM | Description | HCC? |
|---|---|---|
| F10.20 | Alcohol use disorder, moderate, uncomplicated | β |
| F10.21 | Alcohol use disorder, moderate, in remission | β |
| F10.10 | Alcohol abuse, uncomplicated | β |
| F10.99 | Alcohol use disorder, unspecified, with unspecified alcohol-induced disorder | β |
| Z87.891 | Personal history of nicotine dependence | β |
Complications and MCC-Level Diagnoses
| ICD-10-CM | Description | HCC? |
|---|---|---|
| A41.9 | Sepsis, unspecified organism | β HCC 2 |
| A41.89 | Other specified sepsis (SBP-related) | β HCC 2 |
| K65.2 | Spontaneous bacterial peritonitis | β |
| J96.00 | Acute respiratory failure, unspecified | β HCC 84 |
| J18.9 | Pneumonia, unspecified | β |
| J69.0 | Aspiration pneumonitis (aspiration pneumonia) | β |
| N17.9 | Acute kidney injury, unspecified | β |
| K76.7 | Hepatorenal syndrome | β HCC 27 |
| D65 | Disseminated intravascular coagulation | β HCC 38 |
| E43 | Severe protein-calorie malnutrition | β HCC 21 |
| E44.0 | Moderate protein-calorie malnutrition | β HCC 21 |
| E87.1 | Hypo-osmolality and hyponatremia (dilutional β cirrhosis) | β |
| E87.5 | Hyperkalemia | β |
Hepatic Encephalopathy β MCC Capture
Hepatic encephalopathy is one of the most commonly undercoded MCC-level diagnoses in cirrhotic patients admitted for variceal hemorrhage. Per ICD-10-CM guidelines, hepatic encephalopathy is coded as hepatic failure with coma:
- K72.91 β Hepatic failure, unspecified, with coma (MCC β dramatically escalates DRG weight)
- K70.41 β Alcoholic hepatic failure with coma (MCC β for alcoholic cirrhosis patients)
Physicians frequently document βaltered mental status,β βconfusion,β βhepatic encephalopathy,β or βasterixisβ without connecting the encephalopathy to the hepatic failure framework. A clinical documentation query to the treating physician β asking whether the altered mental status represents hepatic encephalopathy and whether this constitutes hepatic failure with coma β is one of the highest-yield query opportunities in hepatology admissions for EVL.
π¨ MS-DRG Mapping
43244 β Predominantly Inpatient Procedure
Unlike many EGD codes that are predominantly outpatient/ASC, 43244 is frequently performed in the inpatient hospital setting β particularly for acute variceal hemorrhage, which almost always requires hospital admission for resuscitation, monitoring, and serial EVL sessions. The principal diagnosis and CC/MCC burden drive DRG assignment.
GI Hemorrhage DRGs β Primary Assignment for Acute Variceal Bleeding
| MS-DRG | Description | Approx. Relative Weight |
|---|---|---|
| 377 | GI Hemorrhage w/ MCC | ~3.0-3.5 |
| 378 | GI Hemorrhage w/ CC | ~1.8-2.2 |
| 379 | GI Hemorrhage w/o CC/MCC | ~1.0-1.3 |
DRG 377 β The Target DRG for Acute Variceal Hemorrhage
DRG 377 (GI Hemorrhage with MCC) is the target DRG for acute variceal bleeding admissions where 43244 is performed. The most reliable pathway to DRG 377:
- I85.01 (esophageal varices with bleeding) as principal
- K72.91 or K70.41 (hepatic failure with coma β hepatic encephalopathy) β MCC
- Or A41.9 (sepsis, e.g., from SBP) β MCC
- Or J96.00 (respiratory failure β intubated patient) β MCC
- Or D65 (DIC β coagulopathy with hemorrhage) β MCC
The difference between DRG 377 (MCC) and DRG 379 (no CC/MCC) can represent 18,000+ in reimbursement at most hospital payment rates. Thorough comorbidity documentation is the primary lever.
Digestive Malignancy DRGs (When HCC is Principal)
| MS-DRG | Description | Approx. Relative Weight |
|---|---|---|
| 374 | Digestive Malignancy w/ MCC | ~2.8-3.2 |
| 375 | Digestive Malignancy w/ CC | ~1.7-2.1 |
| 376 | Digestive Malignancy w/o CC/MCC | ~1.0-1.3 |
Liver Disease / Other GI DRGs (Elective EVL Admissions)
| MS-DRG | Description | Approx. Relative Weight |
|---|---|---|
| 441 | Disorders of Liver Except Malignancy, Cirrhosis, ALD w/ MCC | ~2.8-3.3 |
| 442 | Disorders of Liver Except Malignancy, Cirrhosis, ALD w/ CC | ~1.7-2.1 |
| 443 | Disorders of Liver Except Malignancy, Cirrhosis, ALD w/o CC/MCC | ~1.0-1.3 |
Major GI Procedure DRGs (When EVL Is the Primary OR-Level Procedure)
| MS-DRG | Description | Approx. Relative Weight |
|---|---|---|
| 329 | Major Small & Large Bowel Procedures w/ MCC | ~5.8-6.5 |
| 330 | Major Small & Large Bowel Procedures w/ CC | ~3.2-3.8 |
| 331 | Major Small & Large Bowel Procedures w/o CC/MCC | ~2.0-2.4 |
High-Yield DRG Optimization Queries for 43244 Admissions
The following physician query opportunities are most impactful for EVL (variceal hemorrhage) inpatient admissions:
- Hepatic encephalopathy β Altered mental status, confusion, asterixis, grade 1-4 encephalopathy documented β query for K72.91 or K70.41 (hepatic failure with coma = MCC) β the single highest-impact query in this patient population
- Acute blood loss anemia β Transfusion given for hemorrhage-related hemoglobin drop β D62 (CC); almost universal in acute variceal bleed admissions
- Malnutrition β Cirrhotic patients chronically malnourished; albumin <3.0 g/dL; dietitian documentation β E43 (MCC) or E44.0 (CC)
- Spontaneous bacterial peritonitis (SBP) β Ascites + fever + abdominal pain β diagnostic paracentesis cultures; if SBP documented β K65.2 + A41.89 (sepsis β MCC if sepsis documented)
- Hepatorenal syndrome β Rising creatinine in cirrhotic with variceal hemorrhage β K76.7 (HCC 27)
- Acute kidney injury β Prerenal AKI from hemorrhagic hypovolemia β N17.9 (CC in many groupers)
- Respiratory failure β Aspiration event, intubation for endoscopy, post-procedure respiratory compromise β J96.00 (MCC)
- DIC β Massive hemorrhage with consumption coagulopathy, falling fibrinogen, elevated D-dimer β D65 (MCC β HCC 38)
- Alcohol use disorder β Alcoholic cirrhosis patients; document and code the alcohol use disorder (CC in some groupers) β F10.20
π³ CPT Code Tree β Upper GI Endoscopy / Variceal Management Family
Esophageal and Gastric Variceal Management β Endoscopic
β
βββ 43244 β EGD; WITH BAND LIGATION OF ESOPHAGEAL AND/OR GASTRIC VARICES (THIS CODE)
β βββ EVL β elastic band strangulation; first-line for esophageal varices
β βββ GOV1 gastric varices β EVL appropriate
β βββ All bands in one session = one unit regardless of band count
β
βββ 43243 β EGD; with injection sclerosis of varices
βββ Sclerosant injection β largely replaced by EVL
βββ Selected cases; pediatric; EVL technically not feasible
Upper GI Endoscopy (EGD) Family β Diagnostic and Therapeutic
β
βββ 43235 β EGD; diagnostic (no intervention)
βββ 43239 β EGD; with biopsy (forceps β separately reportable if distinct site)
βββ 43240 β EGD; with transmural drainage of pseudocyst
βββ 43241 β EGD; with US-guided transmural injection
βββ 43242 β EGD; with EUS-guided FNA/biopsy (needle aspiration)
βββ **43244** β BAND LIGATION β VARICES (THIS CODE)
βββ 43243 β EGD; with injection sclerosis of varices
βββ 43245 β EGD; with dilation of gastric outlet for obstruction
βββ 43246 β EGD; with directed PEG tube placement
βββ 43247 β EGD; with removal of foreign body(ies)
βββ 43248 β EGD; with guide wire dilation of esophagus
βββ 43249 β EGD; with dilation of esophagus β€30 mm balloon
βββ 43250 β EGD; with removal by hot biopsy forceps (polypectomy)
βββ 43251 β EGD; with removal by snare technique (snare polypectomy)
βββ 43252 β EGD; with optical endomicroscopy
βββ 43253 β EGD; with US-guided transmural injection of substance
βββ 43254 β EGD; with endoscopic mucosal resection (EMR)
βββ 43255 β EGD; with control of bleeding (non-variceal β separately reportable)
βββ 43257 β EGD; with thermal energy delivery to LES (Stretta)
βββ 43259 β EGD; with endoscopic ultrasound (EUS)
Balloon Tamponade (When EVL Fails)
βββ 43460 β Esophagogastric tamponade β Sengstaken-Blakemore or Minnesota tube
Portosystemic Shunt Procedures (Surgical β When Endoscopic Management Fails)
βββ 37182 β TIPS (transjugular intrahepatic portosystemic shunt) β IR code
βββ 37140 β Venous anastomosis, open; portocaval
βββ 37145 β Venous anastomosis, open; renoportal
βββ 37160 β Venous anastomosis, open; caval mesenteric
βββ 37180 β Venous anastomosis, open; mesocaval, H-graft
Esophageal Varices β Rigid Esophagoscopy (Historical)
βββ 43206 β Esophagoscopy, flexible; with insertion of submucosal injection *(separate from EVL)*
Liver Biopsy (Separately Performed)
βββ 47000 β Liver biopsy, percutaneous needle
βββ 47001 β Liver biopsy, intraoperative needle
Paracentesis (Separately Performed)
βββ 49082 β Paracentesis; without imaging guidance
βββ 49083 β Paracentesis; with imaging guidance
Transnasal Esophagoscopy (Limited Esophageal β Not Appropriate for EVL)
βββ 43197 β Transnasal esophagoscopy, diagnostic
βββ 43198 β Transnasal esophagoscopy with biopsy
ποΈ ICD-10-PCS Context (Inpatient Coding)
Inpatient Coder Note (CIC Relevance)
In the inpatient acute care setting, 43244 is not assigned. All procedures are coded in ICD-10-PCS. Endoscopic variceal band ligation is coded under the Occlusion root operation β partially or completely closing the lumen of a tubular body part (the variceal vessel).
ICD-10-PCS Root Operation for 43244 β EVL
Occlusion β Band Ligation of Esophageal Varices:
| Axis | Value |
|---|---|
| Section | 0 - Medical & Surgical |
| Body System | D - Gastrointestinal System |
| Root Operation | L - Occlusion (completely closing the lumen or orifice of a tubular body part) |
| Body Part | 4 - Esophagogastric Junction OR 5 - Esophagus (depending on variceal location) |
| Approach | 8 - Via Natural or Artificial Opening Endoscopic |
| Device | C - Extraluminal Device (band applied externally to variceal vessel wall β outside the lumen) OR Z - No Device (when band considered integral to approach) |
| Qualifier | Z - No Qualifier |
Occlusion (L) vs. Restriction (V) β EVL Root Operation
The choice between Occlusion (L) and Restriction (V) for EVL depends on the mechanism:
- Occlusion (L) β completely closing the variceal lumen; EVL mechanically strangulates the varix β most facilities use Occlusion (L) for EVL
- Restriction (V) β partially narrowing the lumen without complete closure
The elastic band applied at EVL mechanically strangulates and effectively occludes the variceal vessel β Occlusion (L) is the more anatomically accurate root operation for EVL. Verify with your facilityβs ICD-10-PCS coding guidelines and query resources as this remains an area of variability across facilities.
Alternative β Restriction (V) Approach:
| Axis | Value |
|---|---|
| Section | 0 - Medical & Surgical |
| Body System | D - Gastrointestinal System |
| Root Operation | V - Restriction (partially closing the lumen) |
| Body Part | 5 - Esophagus |
| Approach | 8 - Via Natural or Artificial Opening Endoscopic |
| Device | C - Extraluminal Device |
| Qualifier | Z - No Qualifier |
Device Value β C (Extraluminal Device) for Band Ligation
The rubber band applied during EVL is placed external to the mucosal lumen (the band is applied around the outside of the suctioned pseudopolyp β it is technically an extraluminal device). Therefore:
- Device value = C - Extraluminal Device (rubber band placed around variceal tissue β outside the lumen)
- This distinguishes EVL from endoscopic clip placement (intraluminal device β device value 7) or sclerotherapy injection (no device β substance injected, not a device placed)
Multiple Variceal Columns β PCS Coding
When multiple variceal columns are banded in a single session, ICD-10-PCS typically assigns one code for the root operation on the body part β per Guideline B3.2a (same root operation, same body part, same session = one code). All bands applied to esophageal varices = one Occlusion or Restriction code for Esophagus.
| Scenario | ICD-10-PCS Codes |
|---|---|
| EVL of esophageal varices β multiple bands | Occlusion OR Restriction, Esophagus, Endoscopic, Extraluminal Device (1 code) |
| EVL of esophageal AND gastric varices (GOV1) | Occlusion, Esophagogastric Junction, Endoscopic + Occlusion, Stomach, Endoscopic (2 codes if distinct body parts) |
| EVL of esophageal varices + diagnostic EGD component | Occlusion, Esophagus, Endoscopic β Inspection not separately coded (B3.11b) |
ICD-10-PCS Comparison β EVL vs. Sclerotherapy
| CPT | PCS Root Operation | Device | Rationale |
|---|---|---|---|
| 43244 (EVL) | L - Occlusion | C - Extraluminal Device | Band placed around varix externally |
| 43243 (Sclerosis) | D - Extraction or 3 - Introduction | Z - No Device | Chemical injection β substance, not device |
| 43255 (Bleeding control) | 3 - Administration or specific root op | Varies | Method-dependent |
π Coding Examples
Example 1 β Acute Esophageal Variceal Hemorrhage, Cirrhosis
Clinical Scenario: 54-year-old male with alcoholic cirrhosis (Child-Pugh C, MELD 22) presents to ED with massive hematemesis. BP 88/54, HR 118. IV access obtained; 2 units pRBC transfused; octreotide drip started; ceftriaxone started for SBP prophylaxis. Emergent EGD performed: F3 esophageal varices at GEJ with active spurting hemorrhage from one column. Seven-band ligator loaded. Five bands deployed over three variceal columns at GEJ; active bleeding site banded with one additional band; hemostasis achieved. Patient admitted to ICU.
CPT Code:
- 43244 β EGD with band ligation of esophageal varices (5 bands deployed β one unit; emergent; POS 21 inpatient)
ICD-10-CM:
- I85.01 β Esophageal varices with bleeding (principal β active hemorrhage at procedure)
- K70.31 β Alcoholic cirrhosis of liver with ascites (HCC 27)
- D62 β Acute posthemorrhagic anemia (additional β transfusion given)
- F10.20 β Alcohol use disorder, moderate (additional)
- K76.6 β Portal hypertension (additional)
Example 2 β Elective EVL for Primary Prophylaxis (Large Varices, No Prior Bleed)
Clinical Scenario: 61-year-old female with hepatitis C cirrhosis (confirmed fibrosis stage 4) and newly diagnosed large esophageal varices (F3, red wale marks) on index EGD. Beta-blockers contraindicated (severe asthma). Referred for EVL prophylaxis. Elective EGD: F3 varices with RWM; no active bleeding; four variceal columns. Six bands deployed over four columns at GEJ. No active hemorrhage. First of planned serial EVL sessions.
CPT Code:
- 43244 β EGD with band ligation of esophageal varices (elective prophylaxis; 6 bands; one unit; POS 22 outpatient)
ICD-10-CM:
- I85.00 β Esophageal varices without bleeding (principal β elective prophylaxis; no active bleed)
- K74.69 β Other cirrhosis of liver (HCC 27)
- B18.2 β Chronic viral hepatitis C (HCC 29)
- J45.50 β Severe persistent asthma, uncomplicated (additional β beta-blocker contraindication context)
Example 3 β Secondary Prophylaxis EVL Session (Post-Bleed Eradication Program)
Clinical Scenario: 58-year-old male, 3 weeks post-discharge for acute variceal hemorrhage (index EVL performed at prior admission). Returns for second session of eradication program. EGD: residual F2 varices in two columns; no active bleeding; no red signs. Three bands deployed at two columns. Third session scheduled in 3 weeks.
CPT Code:
- 43244 β EGD with band ligation of esophageal varices (second eradication session; 3 bands; one unit; POS 22)
ICD-10-CM:
- I85.00 β Esophageal varices without bleeding (principal β secondary prophylaxis; no active bleed this session)
- K74.60 β Unspecified cirrhosis of liver (HCC 27)
- K76.6 β Portal hypertension (additional)
Example 4 β EVL with Concurrent Biopsy for H. pylori (Two-Code Case)
Clinical Scenario: 63-year-old male with cirrhosis and known esophageal varices presents for elective EVL (secondary prophylaxis program, session 2). During the EGD, incidental antral nodularity is noted β H. pylori testing indicated. Five bands deployed at three variceal columns (esophageal). After EVL and scope repositioning to antrum: biopsies Γ 4 from gastric antrum and corpus (distinct site from varices; distinct clinical indication β H. pylori testing). Two procedures β EVL and separate biopsy β performed at distinct anatomical sites with distinct indications.
CPT Codes:
- 43244 β EGD with band ligation of esophageal varices (EVL component)
- 43239 β EGD with biopsy (modifier -59 β distinct anatomical site (antrum/gastric vs. esophageal GEJ); distinct clinical indication; verify NCCI)
ICD-10-CM:
- I85.00 β Esophageal varices without bleeding (principal β EVL indication)
- K74.60 β Unspecified cirrhosis of liver (HCC 27)
- K29.60 β Other gastritis without bleeding (additional β antral nodularity; H. pylori testing indication)
Some payers bundle 43239 into 43244 for the same EGD session. Verify current NCCI column assignments before submitting both. If the biopsy is genuinely at a separate anatomical site with a separate clinical indication, modifier -59 on 43239 is the appropriate pathway. Provide documentation showing the EVL was at the esophageal GEJ and the biopsy was at the gastric antrum/corpus β two distinct anatomical regions of the upper GI tract.
Example 5 β Acute Variceal Hemorrhage β EVL + Non-Variceal Bleeding at Separate Site
Clinical Scenario: 67-year-old female with portal hypertension and cirrhosis (NAFLD). Admitted for hematemesis. EGD: F2 esophageal varices at GEJ with one column showing oozing hemorrhage β four bands deployed; hemostasis achieved. On further examination, a separate gastric ulcer (1.2 cm, lesser curvature body, clean base, non-bleeding but adherent clot) is found; injection with 1:10,000 epinephrine + coagulation applied to adherent clot site (concurrent bleeding control at separate non-variceal site).
CPT Codes:
- 43244 β EGD with band ligation of esophageal varices (variceal hemorrhage component)
- 43255 β EGD with control of bleeding (modifier 59 β distinct non-variceal bleeding source at separate anatomical site (gastric body ulcer vs. esophageal GEJ varices); verify NCCI)
ICD-10-CM:
- I85.01 β Esophageal varices with bleeding (principal β active variceal bleed)
- K25.4 β Gastric ulcer, chronic with hemorrhage (additional β concurrent gastric ulcer with adherent clot)
- K74.60 β Unspecified cirrhosis of liver (HCC 27)
- D62 β Acute posthemorrhagic anemia (additional)
When billing both 43244 and 43255 for the same EGD session, the procedure report must clearly document:
- Two distinct bleeding sources at separate anatomical locations
- Two distinct therapeutic interventions β one specifically for varices (EVL) and one for the non-variceal source (injection, cautery, clips)
- Specific locations of each intervention with anatomical measurements (distance from incisors, location descriptors)
- Independent hemostasis assessment for each site
Without this documentation, payers will deny one code as bundled.
Example 6 β EVL with Hepatic Encephalopathy (MCC Capture β Inpatient)
Clinical Scenario: 49-year-old male with decompensated alcoholic cirrhosis (Child-Pugh C), MELD 28. Admitted for variceal hemorrhage (hematemesis + encephalopathy β grade III, not responsive to commands, asterixis). Endotracheally intubated for airway protection prior to EGD. EGD under general anesthesia: F3 varices with active oozing Γ 2 columns. Seven bands deployed; hemostasis achieved. Patient transferred to MICU intubated. ICU course: lactulose/rifaximin initiated for encephalopathy; 3 units pRBC; 2 units FFP; pressors briefly required.
CPT Code:
- 43244 β EGD with band ligation of esophageal varices (emergent; under GA; one unit)
- (Anesthesia billed by separate anesthesia provider β 00740 Γ 13+ base units)
ICD-10-CM:
- I85.01 β Esophageal varices with bleeding (principal)
- K70.41 β Alcoholic hepatic failure with coma (additional β encephalopathy = hepatic failure with coma = MCC) (HCC 27)
- K70.31 β Alcoholic cirrhosis with ascites (additional) (HCC 27)
- F10.20 β Alcohol use disorder, moderate (additional)
- D62 β Acute posthemorrhagic anemia (additional β 3 units pRBC)
- J96.00 β Acute respiratory failure (additional β intubated) (HCC 84 β MCC)
- E43 β Severe protein-calorie malnutrition (additional β if documented) (MCC)
Multiple MCC Stacking β DRG Impact
This case illustrates MCC stacking β multiple MCC-level diagnoses documented in the same admission:
- K70.41 (hepatic failure with coma) β MCC β DRG 377
- J96.00 (respiratory failure) β MCC
- E43 (severe malnutrition) β MCC
Although only one MCC is needed to qualify for DRG 377 (GI Hemorrhage with MCC), capturing all MCCs is essential for accurate risk adjustment (HCC scoring) and complete clinical representation. Each captured MCC also protects the claim against audit by demonstrating the documented severity of illness that justifies the high-cost admission.
Example 7 β Return to Endoscopy Suite for Rebleeding (Global Period)
Clinical Scenario: Patient undergoes EVL for acute variceal hemorrhage (index 43244 performed 2 days ago). Now develops recurrent hematemesis. Urgent repeat EGD performed by same physician same day: fresh blood in esophagus; band ulcer at site of prior EVL with oozing; three additional bands deployed proximal to ulcer site.
CPT Code:
- 43244 with modifier 76 β EGD with band ligation; repeat procedure by same physician, same day (rebleeding from band ulcer β distinct session, same day)
ICD-10-CM:
- I85.01 β Esophageal varices with bleeding (rebleeding episode)
- K70.31 β Alcoholic cirrhosis with ascites (HCC 27)
- D62 β Acute posthemorrhagic anemia
- Modifier -76 β Same procedure repeated by the same physician on the same day at a different time (e.g., morning EVL + afternoon EVL for rebleeding = -76)
- Modifier -78 β Return to the operating room or procedure suite for a related procedure during the postoperative global period (for 43244 with 0-day global, -78 is technically appropriate for same-day returns to the procedure suite; however, -76 is more commonly applied for same-day repeat endoscopy by the same physician)
Verify payer-specific modifier guidance β some payers prefer 78 for same-day returns to the procedure suite; others accept -76 for same-day repeat procedures.
β οΈ Common Coding Pitfalls
- 43244 vs. 43255 for variceal hemorrhage control: When EVL is performed to control active variceal bleeding β always 43244, never 43255. 43255 is for non-variceal bleeding sources. Assigning 43255 for variceal hemorrhage controlled by banding is a misrepresentation of the technique used.
- 43244 vs. 43243 β EVL vs. sclerotherapy: 43244 = band ligation (rubber bands); 43243 = injection sclerosis (chemical sclerosant). These are different techniques and different codes. In contemporary practice, 43243 is rarely used β virtually all variceal endoscopic treatment is 43244.
- Never bill multiple units of 43244: All bands deployed in one session = one unit. Whether 1 band or 10 bands were applied β one unit of 43244. Multiple units will be denied.
- Encephalopathy = hepatic failure with coma β the most impactful undercoded diagnosis: Document βhepatic encephalopathyβ β query for hepatic failure with coma (K72.91 or K70.41) β MCC β DRG 377. This single query can shift an admission from DRG 379 to DRG 377, representing $10,000+ in reimbursement difference.
- I85.01 vs. I85.00 β bleeding status matters: Active hemorrhage = I85.01; prophylactic EVL without current bleed = I85.00. These codes directly affect MS-DRG assignment (GI Hemorrhage vs. Liver Disease DRG family).
- HCC 27 (cirrhosis) should appear on every EVL claim: Cirrhosis (K70.3x, K74.60, K74.69) is the underlying disease driving varices and should be coded at every encounter β including every outpatient EVL session. Failure to capture HCC 27 at each encounter underestimates the patientβs risk score in value-based care.
- Active malignancy vs. personal history: Hepatocellular carcinoma (C22.0 β HCC 11) concurrent with cirrhosis must be coded as active when documented and under management β not personal history. Two separate HCCs (HCC 11 malignancy + HCC 27 cirrhosis) represent the full clinical burden.
- Anesthesia billing: When an anesthesia provider separately administers MAC or GA for 43244 (common in emergent cases), the anesthesiologist/CRNA bills separately β the endoscopist still bills 43244 for the procedural service. Never include anesthesia on the endoscopistβs claim.
- Inpatient coding β ICD-10-PCS: Never assign 43244 for inpatient acute care stays. Use ICD-10-PCS root operation Occlusion (L) or Restriction (V), body part Esophagus, approach Via Natural Opening Endoscopic, device Extraluminal Device (C).
- Modifier -76 documentation for same-day repeat EVL: When urgent repeat EVL is performed same day for rebleeding by the same physician, modifier -76 (or -78 depending on payer) is required with documentation of the separate clinical indication (rebleeding event) distinguishing it from the first session.
π Brief Source References
AMA CPT Professional Edition 2025, codes 43243-43244 and upper GI endoscopy section guidelines CMS Medicare Physician Fee Schedule Final Rule 2025 - Work RVU and payment indicator files (www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched) CMS NCCI Policy Manual for Medicare Services, Chapter 8: Surgery - Digestive System, 2025 CMS MS-DRG Definitions Manual v41 FY2024 - GI Hemorrhage DRGs 377-379; Liver Disease DRGs 441-443 ICD-10-PCS Official Guidelines for Coding and Reporting FY2025 - Root Operations: Occlusion (L), Restriction (V); Guideline B3.2a, B3.11b ICD-10-CM Official Guidelines for Coding and Reporting FY2025 - Section I.C.11 Digestive System; inpatient POA guidelines Section II Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management. Hepatology 2017;65(1):310-335 American Association for the Study of Liver Diseases (AASLD). Practice Guidance on Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis. Hepatology 2022 de Franchis R; Baveno VII Faculty. Renewing consensus in portal hypertension: Baveno VII. J Hepatol 2022;76(4):959-974 AAPC CPC/CIC Study Guide - Surgery: Digestive System / Upper GI Endoscopy and Hemostasis chapter
Crystal's MCW Coder Hub